Marburg, Germany

Mathias Gehrmann


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Location History:

  • Lollar, DE (2006)
  • Marburg, DE (2007)

Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mathias Gehrmann

Introduction

Mathias Gehrmann is an accomplished inventor based in Marburg, Germany. With two patents to his name, he has made significant contributions to the field of biotechnology. His innovative work focuses on the development of fusion proteins that are capable of activating prodrugs, a vital area of research with potential applications in cancer treatment.

Latest Patents

Gehrmann's latest patents revolve around the concept of fusion proteins for prodrug activation. These inventions relate to compounds that include an antigen binding region attached to at least one enzyme. This enzyme is designed to metabolize a prodrug, which is of minimal cytotoxicity, into a cytotoxic compound. The innovative aspect of these compounds lies in the antigen binding region, which is comprised of a single polypeptide chain. Furthermore, it is deemed advantageous for covalently bonded carbohydrates to be present on this polypeptide chain, enhancing its functionality.

Career Highlights

Throughout his career, Mathias Gehrmann has been associated with notable pharmaceutical companies, including Behringer Ingelheim. His role in these companies has allowed him to collaborate with leading professionals in the field, further advancing his research and innovation.

Collaborations

In his professional journey, Gehrmann has had the opportunity to work alongside esteemed colleagues such as Klaus Bosslet and Gerhard Seemann. These collaborations have been instrumental in fostering creativity and innovation, driving research efforts that aim to bridge the gap between theoretical science and practical applications in medicine.

Conclusion

Mathias Gehrmann stands out as a significant figure in the realm of biotechnology. With his innovative patents and fruitful collaborations, he continues to contribute to advancements in medical science, demonstrating the profound impact that dedicated inventors can have on society. His work not only enhances our understanding of prodrug activation but also opens doors for new therapeutic approaches in treating diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…